Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1994 | 06-1994 | 03-1994 | 12-1993 | 09-1993 | |
| Sales | 8,900 | 3,617 | 2,987 | 2,884 | 3,576 |
| Cost of Goods | 0 | 10,344 | 10,755 | -28,548 | 10,619 |
| Gross Profit | 8,900 | -7,052 | -8,547 | 30,435 | -7,914 |
| Operating Expenses | 12,546 | 3,577 | 3,446 | 42,115 | 2,938 |
| Operating Income | -3,646 | -9,960 | -10,459 | -11,231 | -9,362 |
| Interest Expense | 323 | 289 | 273 | 273 | 271 |
| Other Income | 0 | 0 | -1 | 0 | 0 |
| Pre-tax Income | -3,969 | -10,249 | -10,733 | -11,504 | -9,632 |
| Net Income Continuous | -3,968 | -10,249 | -10,733 | -11,505 | -9,632 |
| Net Income | $-3,968 | $-10,249 | $-10,733 | $-11,505 | $-9,632 |
| EPS Basic Total Ops | -0.21 | -0.54 | -0.57 | -0.61 | -0.58 |
| EPS Basic Continuous Ops | -0.21 | -0.54 | -0.57 | -0.61 | -0.58 |
| EPS Diluted Total Ops | -0.21 | -0.54 | -0.57 | -0.61 | -0.58 |
| EPS Diluted Continuous Ops | -0.21 | -0.54 | -0.57 | -0.61 | -1.17 |
| EBITDA(a) | $-3,646 | $-9,960 | $-10,459 | $-11,231 | $-9,362 |